The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
News |
Partnerships build trust between industry and healthcare professionals
News |
Labour budget can unlock UK life science opportunities
Blog |
The first six months of the 2024 Voluntary Scheme
Blog |
Getting ready for the Windsor Framework: ensuring continuity of UK medicines supply beyond 1 January 2025
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
2024 ABPI Code of Practice
Copies of the 2024 ABPI Code are now available to order. Please note we are no longer delivering outside of the UK.
Partnering for progress: a data-driven analysis of NHS-industry partnerships
This world-first research aims to systematically measure how NHS-industry partnerships support improved patient outcomes using data from across the NHS.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
NICE/DSU/ABPI Masterclass: Methods for mapping health utilities for NICE submissions
NICE and the ABPI invite you to the fourth and final event in the NICE/DSU/ABPI Masterclass Programme in 2024 – Methods for mapping health utilities for NICE
Pharma Integrates | 12 November 2024
Attend the Pharma Integrates Conference on 12 November 2024, and save 25% on your ticket using the exclusive ABPI members discount code. Contact our membership team at membership@abpi.org.uk to get the code.
PMCPA Code of Practice Seminar - SOLD OUT
The training will cover the requirements of the Code of Practice and procedures followed by the PMCPA, the Code of Practice Panel and the Code of Practice Appeal Board.
PMCPA Code of Practice Seminar - SOLD OUT
The training will cover the requirements of the Code of Practice and procedures followed by the PMCPA, the Code of Practice Panel and the Code of Practice Appeal Board.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]
Key content hubs
The COP28 summit will bring parties together to accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.